Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pacific Biosciences of California, Inc. ("Pacific Biosciences of California,
LOS ANGELES, CA / ACCESSWIRE / August 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bioscie
Lost Money on Pacific Biosciences of California, Inc.(PACB)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky
07:25am, Thursday, 22'nd Aug 2024
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pacific Biosciences of California, Inc. ("Pacific Biosciences of California,
Shareholders With Losses In Pacific Biosciences Of California Inc Are Invited To Join A Fraud Investigation With The Schall Law Firm
11:00am, Wednesday, 21'st Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bioscie
Pacific Biosciences: Cash Rich, Revenue Poor, Still A 'Sell'
08:14am, Wednesday, 21'st Aug 2024
PacBio's Q2 2024 revenue dropped 24% YoY, primarily due to a sharp decline in instrument sales. Gross margin plummeted to 16%, reflecting increased costs and pricing pressures in a challenging market.
NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pacific Biosciences of California, Inc. ("Pacific Biosciences of California,
Pacific Biosciences: A Speculative Play On Long-Read Genomics Sequencing
09:51pm, Tuesday, 20'th Aug 2024
A weak funding environment for life sciences tools has PacBio trading back below $2, as the company has come in well below prior revenue expectations and taken down mid-term targets. PacBio's Q2 was w
Investors In Pacific Biosciences Of California Inc Are Encouraged To Participate In Fraud Investigation With The Schall Law Firm
11:00am, Tuesday, 20'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bioscie
NEW YORK, NY / ACCESSWIRE / August 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pacific Biosciences of California, Inc. ("Pacific Biosciences of California,
Shareholders With Losses In Pacific Biosciences Of California Inc Invited To Join Fraud Investigation With The Schall Law Firm
11:00am, Monday, 19'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bioscie
Pacific Biosciences of California, Inc. (PACB) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
07:25am, Monday, 19'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pacific Biosciences of California, Inc. ("Pacific Biosciences of California,
Pacific Biosciences Of California Inc Investors Encouraged To Participate In Fraud Investigation With The Schall Law Firm
11:00am, Sunday, 18'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bioscie
Pacific Biosciences Of California Inc Stockholders Invited To Join Fraud Investigation With The Schall Law Firm
11:00am, Saturday, 17'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bioscie
Pacific Biosciences Of California Inc Investors Eligible To Join Fraud Investigation With The Schall Law Firm
11:00am, Friday, 16'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bioscie
NEW YORK, NY / ACCESSWIRE / August 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pacific Biosciences of California, Inc. ("Pacific Biosciences of California,
